Find out if you’re a candidate.

Redefine Healthcare now offers Nevro HFX, an FDA-Approved nondrug treatment for painful diabetic neuropathy. HFX spinal cord stimulation has been proven to safely treat chronic pain for over 10 years in over 100,000 patients by delivering mild electrical pulses to the nerves, interrupting the transmission of pain signals to the brain, thus reducing pain.
HFX is the most effective treatment for shooting, burning, pins and needles pain associated with diabetic neuropathy, providing ongoing relief where conventional treatments fall short and without the associated side effects. HFX isn’t addictive and doesn’t cloud your thoughts or cause drowsiness or constipation like pain medications.
Nevro HFX has gotten me to the point where I know I’ve got my life back.
Getting my HFX stimulator was the best decision of my life.
patients have substantial, lasting pain relief¹
average pain relief¹
of patients were highly satisfied with the treatment process²
1 Petersen, E, et. al. Durability of High-Frequency 10 kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments. Diabetes Care, November 2021.
2 Most effective treatment for refractory. Source: . Petersen E. et al. Effect of high frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology Apr 2021
Once we learned HFX by Nevro was FDA-Approved for painful diabetic neuropathy, it was a game changer for our patients.
Pain Management
Pain Management
Psychiatry & Pain Management
The effects of diabetic neuropathy can significantly impact your quality of life, and if not addressed promptly, may result in complications like ulcers, infections, and in severe cases, the need for amputation. Early diagnosis and intervention offers the best chance for controlling symptoms and preventing these more severe problems.
Diabetic neuropathy is nerve damage from diabetes. It happens most often in the legs and feet, but can affect organs in your body as well.
Symptoms of diabetic neuropathy can include numbness or pain in the hands, feet, or legs. You may also experience problems with your digestive tract, heart, vision, and erectile dysfunction.
Diabetic neuropathy can impair your ability to feel the symptoms of low blood sugar, like feeling dizzy or shaky. This means you may have low blood sugar and not even know it.

10 Parsonage Road Suite 208 Edison, NJ 08837
922 Main Street Suite 201 Paterson, NJ 07503
445 Pleasant Valley Way West Orange, NJ 07052
11 West 25th Street Bayonne, NJ 07002
2500 Morris Avenue Suite 220 Union, NJ 07083
185 Fairfield Avenue Suite 2A West Caldwell, NJ 07006
1255 Broad Street #201B Bloomfield, NJ 07003
Symptoms of diabetic neuropathy can include numbness, tingling, and/or pain in the hands, feet, or legs. You may also experience problems with your digestive tract, heart, vision, and erectile dysfunction.
If you are experiencing symptoms of diabetic neuropathy, we will often conduct nerve testing and/or imaging studies, such as an electromyography (EMG), nerve conduction study, or MRI. This allows us to rule out other potential causes and provide a proper diagnosis.
Prescription medication for diabetic neuropathy may include anti-seizure medication, antidepressants, pain-relieving medication such as acetaminophen, or topical agents. However, medication is often inefficient in relieving symptoms, or patients discontinue use due to side effects.
There are several steps you can take to reduce your risk of developing diabetic neuropathy. Keeping your blood pressure under control, maintaining a healthy diet, being active every day, and not smoking can all help you feel better overall.
There are several steps you can take to reduce your risk of developing diabetic neuropathy. Keeping your blood pressure under control, maintaining a healthy diet, being active every day, and not smoking can all help you feel better overall.
HFX is a small FDA-Approved device that works inside your body to quiet the pain signals, providing long-term relief from painful diabetic neuropathy & improving sleep.¹ Your doctor can answer all of your questions in your consultation when you request an appointment.
In a clinical study, patients who were In a clinical study, patients who were treated with HFX (10 kHz Therapy) experienced 77% average pain (going from an average pain score of 7.7 to 1.7) relief at 12 months.¹
You may be a candidate for HFX if you haven’t found relief with other treatment options like pain medication or surgery and have nerve-related chronic pain or are experiencing pain in your back, trunk, legs, and/or arms.
If your doctor decides that you’re a candidate for HFX, you can try the device in a temporary one-week trial to decide if it’s right for you.
During a quick and minimally invasive procedure, a small device is implanted under the skin, just above the beltline or in the buttocks area. It’s connected to thin, flexible wires that are placed near the spine. Getting your implant is typically an outpatient procedure, which means you will likely go home the same day.
Yes, HFX is covered by all major commercial health plans and Medicare. Specific coverage language and indications may vary by plan type. Please call Redefine Healthcare’s office to confirm your specific plan at (732) 979-2003.
Spinal cord stimulation is covered under the medical benefit of your health insurance plan. Specific coverage language and indications may vary by plan type, and prior authorization of the SCS trial and implant procedure is typically required. Please call Redefine Healthcare’s office to confirm your specific plan at (732) 979-2003.
Redefine Healthcare offers Nevro HFX at several locations in New Jersey.
1 Petersen, E, et. al. Durability of High-Frequency 10 kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments. Diabetes Care, November 2021.
2 Most effective treatment for refractory. Source: . Petersen E. et al. Effect of high frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology Apr 2021